Incretin mimetics therapy has a profitable influence on non-alcoholic fatty liver disease (NAFLD) and neurodegenerative diseases like Alzheimer’s disease or Parkinson’s disease [75,76,77,78,79]. The gene discussed is GCG; the disease is metabolic dysfunction-associated steatotic liver disease.